摘要
目的针对可吸收止血材料管理中存在的问题,探索行之有效的管控措施,确保可吸收止血材料的安全、有效、经济、合理使用。方法制定严格的准入遴选管理制度,规范约束临床使用行为,同时借助信息系统对可吸收止血材料的临床使用情况进行动态监测,对管控效果进行分析。结果2018年4~8月份与2017年同期相比,手术量增长的同时,可吸收止血材料使用量和使用金额大幅下降,人均用量和人均费用明显下降,过度使用的情况显著改善。结论通过严格准入、规范使用、加强监管等一系列管控措施,使可吸收止血材料管理更加规范、使用更加合理。
Objective To explore effective control measures and to ensure the safe,effective,economical and rational use of absorbable hemostatic materials in view of the existing problems in the management of absorbable hemostatic materials.Methods A strict procurement mechanism was established to regulate and constrain the clinical applications.Meanwhile,the clinical use of absorbable hemostatic materials was dynamically monitored by information systems,aiming to analyze management impact.Results Compared with the same period of 2017,the total amount and value of absorbable hemostatic materials used in April to August 2018 decreased drastically with the amount of operative quantity increasing.Consumption and cost per patient obviously decreased,and the overuse of hemostatic materials was well controlled.Conclusion The use of absorbable hemostatic materials could be standardized and reasonable for clinical purpose by high demands of access,use,as well as regulation.
作者
张阳
刘庆
ZHANG Yang;LIU Qing(Department of Purchase & Supply,Qilu Hospital of Shandong University,Jinan Shandong 250012,China;Director's Office,Qilu Hospital of Shandong University,Jinan Shandong 250012,China)
出处
《中国医疗设备》
2019年第8期124-127,共4页
China Medical Devices
关键词
可吸收止血材料
管理现状
准入遴选
使用管控
动态监测
absorbable hemostatic materials
management situation
procurement selection
clinical application control
dynamic monitoring
